AT156344T

Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products

Abstract

[Subject] The piece function of a transplant which attains to a long period of time is secured, and the adequate amount of a required substance, for example, enzyme, and hormone is emitted, or finish crossing other required metabolism to a long period of time. [Solution means] The core containing the useful cell which is a vehicle of immunity interception nature transplantable in order to give activity output or function biologically to an individual, and was distributed in the biocompatibility matrix made from (a) hydrogel, (b) The vehicle of the immunity interception nature containing a jacket with the surface of the external diffusibility which surrounds this core made from biocompatibility hydrogel material that does not contain the above-mentioned cell projected outside from this core. As this raw きた cell, an insulin production cell, adrenal gland enterochromaffin cells, an antibody secretory cell, a fibroblast, a nerve glue astrocyte, a beta cell, and the ovarian cells of a Chinese hamster are desirable, and the alginic acid salt over which the bridge was constructed with the multivalent ion is desirable as a material of this hydrogel. [Selection figure] Nothing

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

68 members in 24 offices

This recordMember, by publication datePriority claim14 more offices are in the list below

Priority claims4

Priority claims
DocumentOfficeKindDate
69240391United States of AmericaA
69240391United States of AmericaA
692403
US19910692403

Members68

Family members, oldest first
DocumentOfficeKind
CA2109085A1CanadaA1
WO9219195A1World Intellectual Property Organization (WIPO)A1
AU2004192AAustraliaA
NO933842LNorwayL
FI934545AFinlandA
EP0585368A1European Patent Office (EPO)A1
EP0585368A4European Patent Office (EPO)A4
CA2149420A1CanadaA1
WO9410950A1World Intellectual Property Organization (WIPO)A1
AU5671394AAustraliaA
JPH06507412AJapanA
NO951914D0NorwayD0
NO951914LNorwayL
HU9501426D0HungaryD0
FI952322AFinlandA
PL309012A1PolandA1
EP0674497A1European Patent Office (EPO)A1
SK62495A3SlovakiaA3
KR950703910ARepublic of KoreaA
LV10906ALatviaA
AU3902095AAustraliaA
AU666118B2AustraliaB2
CZ122795A3CzechiaA3
JPH08503472AJapanA
LV10906BLatviaB
HUT72986AHungaryA
NZ258720ANew ZealandA
EP0585368B1European Patent Office (EPO)B1
AT156344TThis recordAustriaT
EP0674497A4European Patent Office (EPO)A4
DE69221484D1GermanyD1
AU682796B2AustraliaB2
ES2107537T3SpainT3
DE69221484T2GermanyT2
AU687371B2AustraliaB2
GR3025301T3GreeceT3
DK0585368T3DenmarkT3
SG47470A1SingaporeA1
AU6488398AAustraliaA
HK1001832A1Hong Kong, ChinaA1
US5798113AUnited States of AmericaA
US5800828AUnited States of AmericaA
US5800829AUnited States of AmericaA
US5834001AUnited States of AmericaA
AU700766B2AustraliaB2
US5869077AUnited States of AmericaA
US5871767AUnited States of AmericaA
US5874099AUnited States of AmericaA
BR9307455ABrazilA
US5955095AUnited States of AmericaA
US6083523AUnited States of AmericaA
NO308198B1NorwayB1
US6322804B1United States of AmericaB1
US6337088B1United States of AmericaB1
EP0674497B1European Patent Office (EPO)B1
AT220883TAustriaT
DE69332149D1GermanyD1
US2002150603A1United States of AmericaA1
DK0674497T3DenmarkT3
PT674497EPortugalE
ES2179839T3SpainT3
DE69332149T2GermanyT2
CA2109085CCanadaC
US2004185083A1United States of AmericaA1
US6960351B2United States of AmericaB2
CA2149420CCanadaC
JP2007314569AJapanA
JP4215273B2JapanB2